Covered recipient · General Payments record
GRACE BERNAUDO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2023–2024
$355.14
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $318.11 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $83.68 | 4 |
| Insulet Corporation | $60.82 | 3 |
| Lilly USA, LLC | $47.15 | 2 |
| Xeris Pharmaceuticals, Inc. | $42.75 | 2 |
| Amneal Pharmaceuticals LLC | $24.04 | 1 |
| Tandem Diabetes Care, Inc. | $21.03 | 1 |
| Amgen Inc. | $19.43 | 1 |
| Verity Pharmaceuticals Inc. | $19.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.43 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115448369 | CMS |
| Amneal Pharmaceuticals LLC | $24.04 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139207428 | CMS |
| Insulet Corporation | $21.79 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116799462 | CMS |
| Insulet Corporation | $16.20 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116799460 | CMS |
| Insulet Corporation | $22.83 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116809205 | CMS |
| Lilly USA, LLC | $15.91 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135672226 | CMS |
| Lilly USA, LLC | $31.24 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135684001 | CMS |
| Novo Nordisk Inc | $24.94 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100250060 | CMS |
| Novo Nordisk Inc | $18.32 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100491937 | CMS |
| Novo Nordisk Inc | $16.25 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100624094 | CMS |
| Novo Nordisk Inc | $24.17 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100596039 | CMS |
| Tandem Diabetes Care, Inc. | $21.03 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138752555 | CMS |
| Verity Pharmaceuticals Inc. | $19.21 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080602021 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.88 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144626595 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.87 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144626597 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.